Long-term use of GLP-1 agonists increases risks, such as bowel obstruction and pancreatitis.

“And they have increased risk of bowel obstruction, increased risk of pancreatitis, increased risk of, potentially, thyroid issues, of kidney issues.”

“So, for example, initially, we were seeing very little data. And then the data started coming in. And, for example, if you're on it for four years, your risk of bowel obstruction goes up by 4 and 1/2 fold. That's by 450%. Or your risk of pancreatitis goes up by 900%.”